Key result
ADHERE score shows ~0.69 discrimination for in-hospital mortality with admission urea linked to higher risk.
Why the study?
Risk scores help identify acute heart failure patients at high risk of in-hospital death, but need validation across diverse populations with heterogeneous sociodemographic characteristics.
Does the ADHERE risk score accurately predict in-hospital mortality in Brazilian patients hospitalized for acute heart failure?
Cohort (n=304)
No
Does the ADHERE risk score accurately predict in-hospital mortality in Brazilian patients hospitalized for acute heart failure?
The ADHERE risk score underestimated in-hospital mortality risk in a Brazilian cohort of acute heart failure patients, highlighting the need for proper external validation of prognostic scores.
Answers are grounded in this paper and cite their sources.
May warrant caution applying ADHERE score in Brazilian acute HF; leaves open need for local validation of prognostic models.
BACKGROUND: Patients hospitalized for acute heart failure present a high mortality rate, so risk stratification for in-hospital death is of utmost importance. Risk scores can help physicians to identify patients at higher risk, but it is important to validate those scores in different populations, since sociodemographic characteristics may be very heterogeneous. OBJECTIVES: This study aimed to evaluate the ADHERE (Acute Decompensated Heart Failure Registry) risk score in a Brazilian quaternary teaching care center. METHODS: This was a retrospective cohort study involving 304 patients with acute heart failure aged ≥ 18 years old, conducted between September 2019 and July 2022. The primary endpoint was the evaluation of the ADHERE score by analysis of the discriminatory index and classification. The secondary endpoint was the evaluation of other prognostic factors for in-hospital mortality. A p-value < 0.05 was considered statistically significant. RESULTS: ADHERE score presented a discriminatory index of 0.69. ADHERE classification index was suboptimal, since the score did not stratify mortality risk on five strata as proposed originally. Furthermore, the score underestimates risk in the studied population. Admission serum urea was the only isolated prognostic factor for the endpoint (OR 1.043; CI 95% 1.024-1.062; p<0.001). CONCLUSION: The ADHERE risk score cannot be entirely validated in our cohort, since classification was not achieved despite an ideal discriminatory index. Admission serum Urea was the only independent risk factor associated with in-hospital mortality. Our study emphasizes the importance of correct external validation of a prognostic score, especially if the demographic and clinical characteristics of cohorts are not comparable.
No takes yet. Share an insight, caveat, or question.
Wajsbrot et al. (2025) conducted a cohort in Acute heart failure (n=304). ADHERE risk score was evaluated on Evaluation of the ADHERE score by analysis of the discriminatory index and classification for in-hospital mortality. The ADHERE risk score yielded a discriminatory index of 0.69 for in-hospital mortality, while admission serum urea was an independent prognostic factor.
Synapse has enriched 10 related papers. Consider them for comparative context: